These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 32082518)
1. Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial. Amiriani T; Rajabli N; Faghani M; Besharat S; Roshandel G; Akhavan Tabib A; Joshaghani H Middle East J Dig Dis; 2020 Jan; 12(1):27-33. PubMed ID: 32082518 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial. Masoodi M; Mahdiabadi MA; Mokhtare M; Agah S; Kashani AHF; Rezadoost AM; Sabzikarian M; Talebi A; Sahebkar A J Cell Biochem; 2018 Nov; 119(11):9552-9559. PubMed ID: 30132960 [TBL] [Abstract][Full Text] [Related]
3. The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial. Khazdouz M; Daryani NE; Cheraghpour M; Alborzi F; Hasani M; Ghavami SB; Shidfar F Eur J Nutr; 2023 Dec; 62(8):3125-3134. PubMed ID: 37525068 [TBL] [Abstract][Full Text] [Related]
4. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700 [TBL] [Abstract][Full Text] [Related]
5. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467 [TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Feagan BG; Macdonald JK Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Lactocare® Synbiotic Administration on the Serum Electrolytes and Trace Elements Levels in Psoriasis Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Study. Akbarzadeh A; Taheri M; Ebrahimi B; Alirezaei P; Doosti-Irani A; Soleimani M; Nouri F Biol Trace Elem Res; 2022 Oct; 200(10):4230-4237. PubMed ID: 34845600 [TBL] [Abstract][Full Text] [Related]
8. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Chande N; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969 [TBL] [Abstract][Full Text] [Related]
9. Transdermal nicotine for induction of remission in ulcerative colitis. McGrath J; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126 [TBL] [Abstract][Full Text] [Related]
10. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224 [TBL] [Abstract][Full Text] [Related]
11. Probiotics for induction of remission in ulcerative colitis. Mallon P; McKay D; Kirk S; Gardiner K Cochrane Database Syst Rev; 2007 Oct; (4):CD005573. PubMed ID: 17943867 [TBL] [Abstract][Full Text] [Related]
12. Short-term effect of gluten-free diet on disease severity, quality of life, and inflammatory markers among patients with mild to moderate ulcerative colitis: A triple-blind randomized placebo-controlled trial. Alborzi Avanaki F; Ebrahimi Daryani N; Aletaha N; Hesabgar N; Rezaee-Zavareh MS; Hadi R Arab J Gastroenterol; 2024 May; ():. PubMed ID: 38714473 [TBL] [Abstract][Full Text] [Related]
13. Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study. Kucharzik T; Lemmnitz G; Abels C; Maaser C Inflamm Bowel Dis; 2017 Feb; 23(2):261-271. PubMed ID: 28092306 [TBL] [Abstract][Full Text] [Related]
14. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Feagan BG; Macdonald JK Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890 [TBL] [Abstract][Full Text] [Related]
15. Probiotics for maintenance of remission in ulcerative colitis. Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412 [TBL] [Abstract][Full Text] [Related]
16. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dore MP; Bibbò S; Fresi G; Bassotti G; Pes GM Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810233 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A for induction of remission in severe ulcerative colitis. Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Bhattacharyya S; Shumard T; Xie H; Dodda A; Varady KA; Feferman L; Halline AG; Goldstein JL; Hanauer SB; Tobacman JK Nutr Healthy Aging; 2017 Mar; 4(2):181-192. PubMed ID: 28447072 [No Abstract] [Full Text] [Related]